Adult and child immunisation schedule
Download Tasmania’s funded adult and child immunisation schedule.
Funded Immunisation Schedule - Tasmania - October 2021
| Age | Vaccine | Route Given | Antigen | Additional Vaccines |
|---|---|---|---|---|
|
Birth |
HB Vax II Paediatric within 7 days of birth | (IM) |
Hep B |
|
|
6 weeks |
Infanrix Hexa Prevenar 13 Rotarix 6-14 weeks of age |
(IM) (IM) (oral) |
DTPa–hepB–IPV–Hib 13vPCV Rotavirus |
Bexsero (Men B)(IM)^ Aboriginal children and children with specified medical risk conditions# |
|
4 months |
Infanrix Hexa Prevenar 13 Rotarix 10-24 weeks of age |
(IM) (IM) (oral) |
DTPa-HepB-IPV-Hib 13vPCV Rotavirus |
Bexsero (IM)^ Aboriginal children and children with specified medical risk conditions# |
|
6 months |
Infanrix hexa |
(IM) |
DTPa-hepB-IPV-Hib |
Prevenar 13 (IM) Children with specified medical risk conditions# Bexsero (IM)^ All children with specified medical risk conditions# |
| 12 Months |
Priorix or M-M-R II Nimenrix Prevenar 13 |
(SC/IM) (IM) (IM) |
MMR Men ACWY 13vPCV |
HB Vax II Paediatric (IM) Low birthweight (<2000g) and/or preterm (<32 weeks) Bexsero (IM)^ Aboriginal children and children with specified medical risk conditions# |
|
18 months |
Priorix-Tetra or ProQuad Tripacel or Infanrix Act-HIB |
(SC/IM) (IM) (IM) |
MMRV DTPa Hib |
|
|
4 years |
Infanrix IPV or Quadracel | (IM) |
DTPa-IPV |
IPVPneumovax 23 (23vPPV) (IM)# Children with specified medical risk conditions# plus a second dose at least 5 years later |
| Year 7 Students |
Boostrix Gardasil 9 - 2 does 6 months apart |
(IM) (IM) |
dTpa 9vHPV |
|
| Year 10 Students |
Nimenrix (not required if previously received) |
(IM) |
MenACWY |
Catch up for 15 – <20 year olds |
|
Pregnant women |
Adacel or Boostrix Recommended 20–32 weeks Influenza Vaccine≈ During any stage of pregnancy |
(IM) (IM) |
dTpa Influenza |
|
|
Aboriginal Adults |
Prevenar 13 (IM) Aboriginal adults without a risk condition, followed by2 doses of Pneumovax 23 (IM)# |
|||
|
70 years |
Zostavax – Catch up for 71–79 years (until 31 October 2023) Prevenar 13 – 70 Years and over |
(SC) (IM) |
VZV 13vPCV |
State-Funded Programs
| Program | Vaccine | Eligibility |
|---|---|---|
| High risk for Hep B | Engerix-B (IM) | See DoH Public Health Services website for eligibility criteria |
|
Measles program |
M-M-R II (SC/IM) | People born during or after 1966 without documented evidence of two measles containing vaccines or serological evidence of immunity Infants aged 6 to 12 months travelling overseasHIGH |
|
^ |
Bexsero - available for people of all ages with some medical conditions# that increase the risk of Invasive Meningococcal Disease. Catch up is available for all Aboriginal children <2 years of age for 3 years (until June 2023). For further information see online edition of the Australian Immunisation Handbook (AIH). |
|
# |
Specified medical risk conditions - refer to online edition of AIH for additional doses and eligibility. Pneumococcal - people >12 months of age with conditions which increase their risk of pneumococcal require a dose of 13vPCV at diagnosis followed by 2 doses of 23vPPV. The NIP funds some but not all risk conditions (refer to AIH for eligibility and dose intervals). |
|
≈ |
Influenza Program - refer to Funded Influenza Schedule-Tasmania for influenza vaccine information. |
|
* |
Catch up - all people aged less than 20 years, adult refugees and humanitarian entrants are eligible for free catch up vaccines. For further information visit health.gov.au/immunisation |
